Quarterly report · Q2
4021.TEDINET S100QA13
Period2022-04-01 → 2022-09-30
Filed2023-02-21
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amends S100PLK3.
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥109.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥208.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥91.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥28.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥21.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥32.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥53.7bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥22.3bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥32.0bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥22.3bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥23.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥38.8bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥16.3bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥24.1bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥16.4bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥280.2bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥279.7bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥247.4bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥60.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥71.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥219.4bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥208.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥197.4bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥43.9bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥34.7bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥43.9bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥28.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.4bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥43.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥33.8bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥9.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥12.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.1bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥29.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥31.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥167.74 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.58 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥271.88 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.94 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.18 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 77.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.1% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 63
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥5.3bn |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥7.2bn |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥100m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥51.3bn |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-09-30 | −¥14.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥36.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥2.3bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥35.7bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥31.2bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥12.1bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥19.8bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥13.7bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥6.0bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥42.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥34.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥8.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥13.9bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥3.2bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥1.5bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥47.6bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥36.5bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥11.1bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥160.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥123.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥36.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥30.5bn |
| Otherother segments | revenue | 2021-04-01 → 2021-09-30 | ¥10.4bn |
| Otherother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥4.4bn |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6.0bn |
| Otherother segments | segment profit | 2021-04-01 → 2021-09-30 | −¥3m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥39.9bn |
| Reconciling Itemsreconciling | revenue external | 2021-04-01 → 2021-09-30 | −¥10.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥29.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥2.5bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥24.9bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥22.8bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E00759-000Agricultural Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥6.9bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥17.1bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥11.7bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥5.4bn |
| jpcrp040300-q2r_E00759-000Chemical Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥39.6bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥34.0bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥5.6bn |
| jpcrp040300-q2r_E00759-000Functional Materialsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥13.1bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥19m |
| jpcrp040300-q2r_E00759-000Medicinesreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.4bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥36.4bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥25.7bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥10.8bn |
| jpcrp040300-q2r_E00759-000Wholesalereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥131.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥101.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥29.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥23.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 576
| Item | Context | Value | Unit |
|---|---|---|---|
| Long term loans receivable | CurrentQuarterInstant | 0 | JPY |
| Deferred tax assets | Prior1YearInstant | 918000000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 467000000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 1844000000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 2497000000 | JPY |
| Other ioa | Prior1YearInstant | 3256000000 | JPY |
| Other ioa | CurrentQuarterInstant | 3110000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -110000000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentQuarterInstant | -110000000 | JPY |
| Investments and other assets | Prior1YearInstant | 39450000000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 35859000000 | JPY |
| Noncurrent assets | Prior1YearInstant | 104408000000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 108416000000 | JPY |
| Assets | Prior1YearInstant | 279687000000 | JPY |
| Assets | CurrentQuarterInstant | 280233000000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 19043000000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 19019000000 | JPY |
| Short term loans payable | Prior1YearInstant | 20981000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 8235000000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant | 552000000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant | 510000000 | JPY |
| Income taxes payable | Prior1YearInstant | 8710000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 7974000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 2285000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 2345000000 | JPY |
| Other cl | Prior1YearInstant | 14398000000 | JPY |
| Other cl | CurrentQuarterInstant | 17442000000 | JPY |
| Current liabilities | Prior1YearInstant | 65971000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 55527000000 | JPY |
| Long term loans payable | Prior1YearInstant | 1182000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 948000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 69000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 104000000 | JPY |
| Provision for business structure improvement ncl | Prior1YearInstant | 698000000 | JPY |
| Provision for business structure improvement ncl | CurrentQuarterInstant | 544000000 | JPY |
| Provision for loss on business of subsidiaries and affiliates ncl | Prior1YearInstant | 626000000 | JPY |
| Provision for loss on business of subsidiaries and affiliates ncl | CurrentQuarterInstant | 626000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | Prior1YearInstant | 200000000 | JPY |
| Provision for share based remuneration for directors and other officers ncl | CurrentQuarterInstant | 170000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 290000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 350000000 | JPY |
| Other ncl | Prior1YearInstant | 2638000000 | JPY |
| Other ncl | CurrentQuarterInstant | 2567000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 5706000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 5312000000 | JPY |
| Liabilities | Prior1YearInstant | 71678000000 | JPY |
| Liabilities | CurrentQuarterInstant | 60839000000 | JPY |
| Capital stock | Prior1YearInstant | 18942000000 | JPY |
| Capital stock | CurrentQuarterInstant | 18942000000 | JPY |
| Capital surplus | Prior1YearInstant | 13613000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |